The role of blinatumomab in ALL
How can standard risk multiple myeloma (MM) patients be cured?
How next-generation sequencing will change the treatment of multiple myeloma
New aims and next steps for adult ALL induction therapy
Current therapy for CLL and the new monoclonal antibody ofatumumab